Live Breaking News & Updates on Rare diseases

Stay informed with the latest breaking news from Rare diseases on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rare diseases and stay connected to the pulse of your community

Truqap recommended for EU breast cancer approval | Company Announcement

Investegate announcements from Truqap recommended for EU breast cancer approval

Canada , United-kingdom , Cambridge , Cambridgeshire , Japan , Daiichi-sankyo , Adrian-kemp , Astrazeneca-truqap , Merck-co-inc , Committee-for-medicinal-products-human-use , National-cancer-institute , Astrazeneca

ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow

ENHERTU demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines of...

Japan , Cambridge , Cambridgeshire , United-kingdom , Canada , Jerusalem , Israel-general- , Israel , Daiichi-sankyo , Trastuzumab-deruxtecan , Capecitabine-monotherapy , End-results-program

Truqap plus Faslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer

AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been recommended for approval in the European Union (EU) for the treatment of adult patients with estrogen receptor (ER)-positive, HER2‑negative locally advanced or metastatic breast cancer with one or more PIK3CA, AKT1, or ...

United-kingdom , Canada , Japan , Cambridge , Cambridgeshire , Astrazeneca-truqap , Daiichi-sankyo , Cancer-research-technology , Committee-for-medicinal-products-human-use , World-health-organization , Investor-relations-team , National-comprehensive-cancer-network

Profluent Releases AI-Created and Open-Source Gene Editor & More - This Week in RARE Daily

Profluent Releases AI-Created and Open-Source Gene Editor & More - This Week in RARE Daily
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United-kingdom , Rett-syndrome-research-trust , Million-to-launch-rare-disease-research-centers , Rett-syndrome-research-trust-partners , Global-genes , Open-source-gene , Arc-invests , Launch-rare-disease-research , Lifearc-translational-centres , Rare-diseases , Accelerated-approval

RCR Race Preview: Dover Motor Speedway - Speedway Digest

RCR Race Preview: Dover Motor Speedway - Speedway Digest
speedwaydigest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from speedwaydigest.com Daily Mail and Mail on Sunday newspapers.

Delaware , United-states , California , Connecticut , Nevada , Maryland , Dover , Menlo-park , New-hampshire , America , Riley-herbst , Austin-dillon

RCR Race Preview: Dover Motor Speedway | SpeedwayMedia.com

Richard Childress Racing has four NASCAR Cup Series victories at Dover Motor Speedway. Dale Earnhardt won three times, including a sweep of both races in 1989 and the 1993 spring event.

Dover , Maryland , United-states , New-hampshire , Connecticut , Nevada , California , Delaware , Menlo-park , America , Austin-hill , Chandler-smith

LifeArc launches £40M research centres that will unlock new tests, treatments and cures for people living with rare diseases

LifeArc launches £40M research centres that will unlock new tests, treatments and cures for people living with rare diseases Thousands of people living with rare medical conditions will get access to improved tests, treatments and potentially cures, thanks to the creation of four new LifeArc Translational...

United-kingdom , Cambridge , Cambridgeshire , Nottingham , Manchester , Edinburgh , City-of , Belfast , Lothian , Midlothian , Brompton , Medway

Perrigo (PRGO) Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to EUR 275M

Perrigo (PRGO) Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to EUR 275M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , Patrick-lockwood-taylor , Works-council , Pharma-works-council , Perrigo-company , Consumer-self-care-products , Esteve-healthcare , Rare-diseases , Perrigo-president , Chief-executive , Staffan-sch , Chief-executive-officer

Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln

Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Patrick-lockwood-taylor , Dennis-riedl , Perrigo-company , Morgan-stanley-co , Consumer-self-care-products , Esteve-healthcare , Rare-diseases , Perrigo-president , Chief-executive , Aktien-sie

AstraZeneca upbeat as cancer drugs underpin sales growth

AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Shares in AstraZeneca rose 5.2% to 11,942.00 pence...

Cambridge , Cambridgeshire , United-kingdom , Jeremy-cutler , Pascal-soriot , Daiichi-sankyo-co-ltd , Alliance-news-ltd , Astrazeneca , Alliance-news , United-kingdom-based , Rare-disease , Rare-diseases